[Home ] [Archive]   [ فارسی ]  
:: Main :: About :: Current Issue :: Archive :: Search :: Submit :: Contact ::
:: Volume 23, Issue 5 (Bimonthly 2019) ::
Feyz 2019, 23(5): 535-542 Back to browse issues page
Evaluation of Serum malondialdehyde concentrations and enzymatic activity of paraoxonase and arile esterase in women with a recurrent spontaneous abortion
Maryam Sanjadi , Hashem Naieri *
Department of Biochemistry, Islamic Azad University of Falavarjan Branch, Isfahan, I. R. Iran. , Hashem.nayeri@yahoo.com
Abstract:   (2464 Views)
Background: Recurrent spontaneous abortion (RSA) is considered as a harmful event for couples, and can lead to serious problems such as anxiety and depression in couples. Malondialdehyde (MDA) is involved in a variety of disorders including spontaneous abortion (RSA). Paraoxonase and Ariel Esterase are antioxidant enzymes with various protective effects. This study aimed to investigate the relationship between serum MDA level and enzymatic activity of paraoxonase and arile esterase enzymes with RSA risk.
Materials and Methods: In this case-control study, 53 RSA patients and 47 healthy age- and sex-matched subjects as the control group were enrolled in the study. Level of MDA were determined in serum sample by using a calorimetrically method with thiobarbituric acid (TBA). The activity of enzymes Paraoxonase and arylesterase were measured by spectrophotometry.  
Result: The mean serum level of MDA was significantly increased in RSA patients compared to a healthy control group (5.85±1.00 vs. 5.47±0.77, P<0.05). We did not observe any significant difference between two groups in mean activity of enzymes Paraoxonase and arylesterase. We found a positive statistical correlation between the serum levels of MDA and anti-paternal cytotoxic antibody (APCA) (r=+0.20, P=0.04).
Conclusion: The present study reveals that oxidative stress and lipid peroxidation in women with a history of spontaneous abortion may increase and subsequently may play a role in non-pregnant women with a history of RSA. Therefore, the increase of oxidative stress in women with a history of RSA is not related solely to pregnancy.
Keywords: Recurrent abortion, Oxidative stress, Malondialdehyde, Paraoxonase, Arylesterase
Full-Text [PDF 374 kb]   (1114 Downloads)    
Type of Study: Research | Subject: medicine, paraclinic
Received: 2018/11/25 | Revised: 2019/12/17 | Accepted: 2019/07/30 | Published: 2019/12/16
1. Ford HB, Schust DJ. Recurrent pregnancy loss: etiology, diagnosis, and therapy. Rev Obstet Gynecol 2009; 2(2): 76.
2. Nunes DP, Spegiorin LC, Mattos CC, Oliani AH, Vaz-Oliani DC, Mattos LC. The ADA* 2 allele of the adenosine deaminase gene (20q13. 11) and recurrent spontaneous abortions: an age-dependent association. Clin 2011; 66(11): 1929-33.
3. El Hachem H, Crepaux V, May-Panloup P, Descamps P, Legendre G, Bouet PE. Recurrent pregnancy loss: current perspectives. Int J Womens Health 2017; 9: 331.
4. Agarwal A, Gupta S, Sharma RK. Role of oxidative stress in female reproduction. Reprod Biol Endocrinol 2005; 3(1): 28.
5. Gulum M, Gumus K, Yeni E, Dogantekin E, Ciftci H, Akin Y, et al. Blood and semen paraoxonase—arylesterase activities in normozoospermic and azoospermic men. Androl 2017; 49(9): e12752.
6. Gil-Villa AM, Cardona-Maya W, Agarwal A, Sharma R, Cadavid Á. Role of male factor in early recurrent embryo loss: do antioxidants have any effect?. Fertil Steril 2009; 92(2): 565-71.
7. Kim DS, Marsillach J, Furlong CE, Jarvik GP. Pharmacogenetics of paraoxonase activity: elucidating the role of high-density lipoprotein in disease. Pharmacogenomics 2013; 14(12): 1495-515.
8. Mackness M, Mackness B. Human paraoxonase-1 (PON1): Gene structure and expression, promiscuous activities and multiple physiological roles. Gene 2015; 567(1): 12-21.
9. Krzystek-Korpacka M, Boehm D, Matusiewicz M, Diakowska D, Grabowski K, Gamian A. Paraoxonase 1 (PON1) status in gastroesophageal malignancies and associated paraneoplastic syndromes—connection with inflammation. Clin Biochem. 2008; 41(10-11): 804-11.
10. Mackness MI, Durrington PN, Mackness B. The role of paraoxonase 1 activity in cardiovascular disease. Am J Cardiovasc Drugs 2004; 4(4): 211-7.
11. Dirican M, Akça R, Sarandol E, Dilek K. Serum paraoxonase activity in uremic predialysis and hemodialysis patients. J Nephrol 2004; 17(6): 813-8.
12. Durrington PN, Mackness B, Mackness MI. Paraoxonase and atherosclerosis. Arterioscler Thromb Vasc Biol 2001; 21(4): 473-80.
13. Serhatlioglu S, Gursu MF, Gulcu F, Canatan H, Godekmerdan A. Levels of paraoxonase and arylesterase activities and malondialdehyde in workers exposed to ionizing radiation. Cell Biochem Funct 2003; 21(4): 371-5.
14. Aviram M, Rosenblat M, Billecke S, Erogul J, Sorenson R, Bisgaier CL, et al. Human serum paraoxonase (PON 1) is inactivated by oxidized low density lipoprotein and preserved by antioxidants. Free Radic Biol Med 1999; 26(7-8): 892-904.
15. Camuzcuoglu H, Arioz DT, Toy H, Kurt S, Celik H, Erel O. Serum paraoxonase and arylesterase activities in patients with epithelial ovarian cancer. Gynecol Oncol 2009; 112(3): 481-5.
16. Jarvik GP, Tsai NT, McKinstry LA, Wani R, Brophy VH, Richter RJ, et al. Vitamin C and E intake is associated with increased paraoxonase activity. Arterioscler Thromb Vasc Biol 2002 1; 22(8): 1329-33.
17. Précourt LP, Amre D, Denis MC, Lavoie JC, Delvin E, Seidman E, et al., The three-gene paraoxonase family: physiologic roles, actions and regulation. Atheroscler 2011; 214(1): 20-36.
18. Solati M, Raiszadeh F, Azizi FE. Lipids, apolipoproteins, lipid oxidation and paraoxonase enzyme activity In diabetic and non-diabetic end stage renal disease patients. Int J Endocrinol Metab 2008; 4: 175-82.
19. Modaresi A, Nafar M, Sahraei Z. Oxidative stress in chronic kidney disease. Iran J Kidney Dis 2015; 9(3): 165.
20. Kural BV, Örem C, Uydu HA, Alver A, Örem A. The effects of lipid-lowering therapy on paraoxonase activities and their relationships with the oxidant–antioxidant system in patients with dyslipidemia. Coron Artery Dis 2004; 15(5): 277-83.
21. Ayar G, Atmaca YM, Alışık M, Erel Ö. Effects of paraoxonase, arylesterase, ceruloplasmin, catalase, and myeloperoxidase activities on prognosis in pediatric patients with sepsis. Clin Biochem 2017; 50(7-8): 414-7.
22. Gałczyński K, Bełtowski J, Nowakowski Ł, Vasilevska D, Rechberger T, Semczuk A. Serum paraoxonase 1 activity and protein N-homocysteinylation in primary human endometrial cancer. Tumour Biol 2018; 40(9): 1010428318797869.
Send email to the article author

Add your comments about this article
Your username or Email:


XML   Persian Abstract   Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Sanjadi M, Naieri H. Evaluation of Serum malondialdehyde concentrations and enzymatic activity of paraoxonase and arile esterase in women with a recurrent spontaneous abortion. Feyz 2019; 23 (5) :535-542
URL: http://feyz.kaums.ac.ir/article-1-3755-en.html

Creative Commons License
This open access journal is licensed under a Creative Commons Attribution-NonCommercial ۴.۰ International License. CC BY-NC ۴. Design and publishing by Kashan University of Medical Sciences.
Copyright ۲۰۲۳© Feyz Medical Sciences Journal. All rights reserved.
Volume 23, Issue 5 (Bimonthly 2019) Back to browse issues page
مجله علوم پزشکی فیض Feyz Medical Sciences Journal
Persian site map - English site map - Created in 0.04 seconds with 30 queries by YEKTAWEB 4570